Gilead will deliver the drug to the US-based on more than 500,000 courses of treatment.
The US Department of health and social security on Monday announced an agreement to supply the drug remdesivir from Gilead Sciences until the end of September, which will allow American hospitals to purchase the drug in quantities determined by the Ministry of health and state health departments.
“President Trump has entered into an amazing agreement to ensure that Americans have access to the first authorized drug for COVID-19,” said health secretary Alex Azar. – We want to make sure that any American patient who needs remdesivir can get it, if possible. The Trump administration is doing everything it can to learn more about COVID-19 drugs and make them available to the American people.”
The Ministry of Health has provided more than 500,000 courses of treatment with the drug for American hospitals by the end of September. This represents 100 percent of Gilead’s planned production for July (94,200 treatment courses), 90 percent of production in August (174,900 treatment courses), and 90 percent of production in September (232,800 treatment courses) in addition to the doses allocated for clinical trials.
To complete the course of treatment with remdesivir to an average of 6.25 bottles. AmerisourceBergen will supply the drug. Hospitals will buy the medicine at a wholesale price, which is about $ 3,200 per course of treatment.
As a rule, patients do not pay directly for the drugs they are treated with in the hospital. Under Medicare and most private insurance programs, the cost of the drug is included in payments made by the insurer. Supplies will be distributed in the same way as about 120,000 courses previously donated by Gilead: The Department of Health distributes the product to state health departments based on how many patients with COVID-19 are in local hospitals and departments distribute it to hospitals.
Delivery of the purchased remdesivir will be accelerated, and it will be sent directly to hospitals, rather than to health departments. Shipments are likely to be made every two weeks. The last batch of doses donated by Gilead will be sent on June 29.